CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment

Lucy L Chen, G. V. Ramesh Prasad
ISSN / E-ISSN
— / —
DOI
10.2147/pgpm.s107710 ↗
Volume · Issue · Pages
Volume 11 · — · 23-33
Publisher
Dove Medical Press Ltd.
Article URL
https://doi.org/10.2147/pgpm.s107710 ↗
Article details
Unverified
Publication date (each date has its type and source)
01 Mar 2018
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date01 Mar 2018 OpenAlex

Keywords (as given): CYP3A5 polymorphism; tacrolimus; kidney transplantation; pharmacogenomics; tacrolimus dosing; pharmacokinetics; genotype-based dosing; calcineurin inhibitors; drug interactions; fluconazole; nephrotoxicity

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Pharmacogenomics and Personalized Medicine
Publication date used
01 Mar 2018 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.